An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.

A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.

An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.

Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.